The Prosthetic Heart Valve market size is USD 14.7 Bn in 2026.
The Prosthetic Heart Valve market is projected to grow at a CAGR of 8% by 2033, reaching USD 25.9 Bn.
The Prosthetic Heart Valve market growth drivers include rising prevalence of heart valve diseases, increasing demand for transcatheter heart valves, and aging population.The Prosthetic Heart Valve market growth drivers include rising prevalence of heart valve diseases, increasing demand for transcatheter heart valves, and aging population.
The U.S. is a dominating region for Prosthetic Heart Valve market.
Medtronic plc, Edwards Lifesciences Corporation, Abbott Laboratories, Boston Scientific Corporation, and St. Jude Medical are some leading industry players in the Prosthetic Heart Valve market.